We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Blood coagulation cascades
- Program
- Domain organization of prothrombin
- Prethrombin 2 activation
- PPACK human alpha-thrombin
- Sodium binding effects
- PPACK - thrombin
- HCII - S195A thrombin
- Substrate specificity
- Uneven charge distribution of thrombin surface
- Dissection of the thrombin surface
- Hirudo medicinalis
- Thrombin-hirudin complex
- Exosite I interaction
- Rhodnius prolixus
- Thrombin-rhodniin complex
- Alpha-thrombin - Rhodniin interaction
- Ornithodorus moubata
- Thrombin-ornithodorin complex
- Ornithodorin D1-BPTI
- Thrombin-BPTI complex
- Allostery of thrombin
- Molecular flexibility of thrombin active site
- Substrate interaction
- Activation of PAR1
- Interaction with PAR1
- Interaction with FPA
- Substrates and acidic region of thrombin
- Thrombin-FPA-hirugen complex
- Thrombin-fibrin E - simultaneous activation
- Thrombin-fibrin E contacting segments
- Fibrinogen-thrombin interactions
- Thrombin-triabin complex
- Staphylococci and staphylocoagulase
- Staphylocoagulase-prethrombin-2 complex
- Activation by staphylocoagulase
- Fibrinogen cleavage by prethrombin - SC complex
- Thrombin-fibrin complex
- Blockage of fibrinogen activation
- Thrombin-NAPAP complex
- Melagatran and the prodrug Ximelagatran
- Exosite II = heparin binding site
- Thrombin-heparin interaction
- Thrombin-ATIII-heparin
- Thrombin-HCII interaction
- Thrombin-kringle 2 interaction
- Thrombin-haemadin complex
- Thrombin modification by thrombomodulin
- Thrombomodulin structure
- Thrombin-TME4,5,6 complex
- Thrombin-TM-PC complex
- Thrombomodulin-assisted protein C activation
- Thrombomodulin-assisted TAFI activation
- PC epitopes in presence/absence of TM
- Plasmin-staphylokinase
- Interaction scheme
- Acknowledgements
Topics Covered
- Coagulation
- Prothrombin activation
- Thrombin structure and surface
- Anion binding exosite I
- Specific thrombin inhibitors from haematophagous animals
- Interaction with the PARs
- Fibrinogen
- Staphylocoagulase
- Direct thrombin inhibitors
- Heparin binding
- Thrombomodulin binding and function
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Bode, W. (2015, August 31). Structure of thrombin, a Janus-headed proteinase [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 3, 2024, from https://doi.org/10.69645/DLII2702.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Wolfram Bode has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Structure of thrombin, a Janus-headed proteinase
A selection of talks on Cell Biology
Transcript
Please wait while the transcript is being prepared...
0:00
Hello. My name is Wolfram Bode.
I'm from the Max-Planck-Institute of Biochemistry in Martinsried, Munich, Germany.
In the following, I'd like to present
some structural features of the coagulation Proteinase Thrombin,
and to show that it is an extremely versatile Janus-Headed Proteinase with
distinct surface regions involved in recognition, binding and catalysis.
0:23
Our blood coagulation system consists of vascular,
cellular and numerous other components.
In this lecture, I will concentrate on the latter.
Coagulation is mainly initiated by this extrinsic pathway an
amplification cascade in which a few trypsinogen like pro enzymes such as factors seven,
nine, 10 and two prothrombin, here represented
by pink spheres, activate each other in successive order,
to the yellow pacman-like actofactors.
This way, any vessel injury induce inflammation of the tissue in factor,
factor seven A complex,
the so-called extrinsic 10Ase triggers the burst like
release of the soluble active alpha Thrombin factor 2A into the vessel lumen.
Thrombin is the main executioner of this cascade,
in that it fulfills
some procoagulant factions that arose such as: conversion of fibrinogen to fibrin,
a cleaving off the two fibrin peptides A and the two fibrin peptides B,
activation of the cross-linking trans glutaminase factor 13,
stimulation of the platelets by cleaving the protease-activated receptors first.
Activation of co-factors five and eight,
which then become brown triangles part of the intrinsic 10ase of the prothrombinase
as well as activation of factor 11,
thus catalyzing further generation of Thrombin,
as well as stimulation of other cells.
But Thrombin can also adopt anticoagulant and antifibronolytic factors,
that it binds in the small capillaries in particular to
the membrane protein Thrombomodulin blocks these programmed properties,
but enables Thrombin to bind and activate protein C, yellow arrows.
Activated protein C in turn is able to degrade these cofactors,
factor 8a and factor 5a, shutting down further Thrombin generation.
All of these activation steps are controlled and regulated by protein inhibitors,
purple triangles, such as Serpins,
antithrombin three and heparin cofactor two, AT3 and HC2.
These inhibitor reactions are assisted by negatively charged carbenoids, particularly heparin.
In most of these factors and complexes about the phospholipid membranes PL mediated by enzymes.
The question therefore arises,
how can a single relatively small protein Thrombin fulfill so many different functions,
interact with so many different substrates, cofactors,
mediators and how are these different functions coordinated?